Table 2.
Prevalence of vaccine coverage, valid doses and length of delay for all doses included in the first year of life, Assis Brasil, 2010
| Vaccine and dose | N | Children that took the dose | Proper age (in days) for a valid dose | Prevalence of valid doses a,b n % | Average days of delay | Minimum days of delay | Maximum days of delay | ||
|---|---|---|---|---|---|---|---|---|---|
| n | % | N | % | ||||||
| BCG | 282 | 281 | 99.7 | 1 | 202 | 72.2 | 25.7 | 1.5 | 501 |
| HepB 1st dose | 281 | 280 | 99.6 | 1 | 213 | 76.1 | 19.5 | 1 | 995 |
| HepB 2nd dose | 281 | 274 | 97.5 | 30 | 194 | 70.8 | 30.6 | 5 | 629 |
| HepB 3rd dose | 281 | 266 | 94.7 | 180 | 137 | 51.5 | 55.2 | 16.5 | 838 |
| DTP-Hib 1st dose | 281 | 268 | 95.4 | 60 | 158 | 59.2 | 32.0 | 7 | 934 |
| DTP-Hib 2nd dose | 281 | 263 | 93.6 | 120 | 159 | 60.7 | 35.5 | 8 | 888 |
| DTP-Hib 3rd dose | 281 | 256 | 91.1 | 180 | 158 | 62.0 | 33.2 | 7 | 373 |
| OPV 1st dose | 281 | 276 | 98.2 | 60 | 166 | 60.1 | 41.3 | 7 | 1520 |
| OPV 2nd dose | 281 | 271 | 96.4 | 120 | 166 | 61.3 | 39.6 | 8 | 888 |
| OPV 3rd dose | 281 | 260 | 92.5 | 180 | 153 | 58.8 | 37.0 | 9 | 705 |
| ORV 1st dose | 221 | 152 | 69.1 | 60 | 96 | 63.2 | 23.2 | 5 | 550 |
| ORV 2nd dose | 221 | 116 | 52.7 | 120 | 83 | 71.6 | 13.4 | 3 | 383 |
| Yellow Fever | 281 | 266 | 94.7 | 270 | 106 | 39.8 | 69.5 | 16 | 1028 |
| MMR | 281 | 256 | 91.1 | 365 | 99 | 38.7 | 68.6 | 18 | 854 |
| Hepatitis B (3 doses) | 281 | 266 | 94.7 | 78 | 28.2 | ||||
| ORV (2 doses) | 221 | 116 | 52.7 | 67 | 47.2 | ||||
| OPV (3 doses) | 281 | 260 | 92.5 | 75 | 27.9 | ||||
| DTP-Hib (3 doses) | 281 | 256 | 91.1 | 78 | 29.8 | ||||
| Complete vaccine status for the first year of life c | 282 | 233 | 82.6 | 6 | 2.3 | ||||
The table depicts the number of children that took each vaccine dose, frequency of valid doses (taken until 7 days after the ideal age in days) and age (in days) considered adequate for a valid dose, and time of delay (average, minimum and maximum days of delay). The lower portion of the table shows summarized data for vaccines that require multiple doses (HBV, ORV, OPV and DTP-Hib). The last line show how many children had completed their vaccination for the first year of life, taking into account all doses received until the date of the interview, except for ORV doses. aValid dose = taken until 7 days after the ideal age in days; b only doses with a understandable date were computed; c ORV doses not included.